http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08113563-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7dfd84f9157ae12c41e319ec325338d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 |
| filingDate | 1994-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_349620b77ff56e96d422840377bd02d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca88da3bb9f638bc85db18aba8b06772 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5921be9568512622a8dbc325dc6d220 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a57b75ab8e069b4bd662868f60ef039 |
| publicationDate | 1996-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H08113563-A |
| titleOfInvention | Novel heterocyclic derivative and platelet aggregation inhibitor |
| abstract | (57) [Summary] (Modified) [Structure] A novel heterocyclic derivative represented by the general formula (I), and a platelet aggregation inhibitor containing the compound. [In the formula, X represents CH 2 or NH; Y represents -CO-N (R 1) - (CHR 2) a -CO-, etc., B is bond (CH 2) p-like;; A is the formula (II) or a group of the formula (III) D, E, F , G is O, S, N, CH, bonds, etc .; Z Is O or CH 2 ; R 1 H, lower alkyl, etc .; R 2 Is H, lower alkyl, benzyl, 4-hydroxybenzyl and the like; R 6 is H, a lower alkyl group or an ester residue removed under physiological conditions; p is, for example, 2 or 3; As shown, or R 1 and R 2 may combine to form a 5- or 6-membered ring. [Effect] The compound of the formula (I) is a platelet aggregation inhibitor that has no side effects caused by low selectivity of inhibitory action and bleeding, etc., and prevents thrombotic diseases such as cerebral infarction and myocardial infarction. Used for treatment. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9736887-A1 |
| priorityDate | 1994-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 187.